A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of Two Doses of Intra-Articular Injection of Ampion in Adults With Pain Due to Osteoarthritis of the Knee

Trial Profile

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of Two Doses of Intra-Articular Injection of Ampion in Adults With Pain Due to Osteoarthritis of the Knee

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Nov 2017

At a glance

  • Drugs DMI 9523 (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Acronyms SPRING
  • Sponsors Ampio Pharmaceuticals
  • Most Recent Events

    • 22 Nov 2017 Pooled analysis of this and 2 other trials (see CT profiles 225451 and 261154) has been published in Orthopedics, according to an Ampio Pharmaceuticals media release.
    • 09 Jun 2015 Results published in Stem Cell Translational Medicine on June 3, 2015, according to an Ampio Pharmaceuticals media release.
    • 02 Sep 2014 Efficacy and safety data from this trial will be used in the BLA for DMI 9523, which is expected to be submitted before the end of quarter 1, 2015, according to an Ampion media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top